Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study

Pablo Tolosa, Eva Ciruelos, Olga Martínez‐Sáez et al.|European Journal of Cancer|2025

Cited by 10